Latest news
OTLK Stock Soars 28% After FDA Sets July Date For Lytenava Decision - StocktwitsStocktwits · Sat, 08 Aug 2026 07:13:33 GMTOTLK Stock Rocket Nearly 140%: FDA's Lytenava FDR Approval Pushes Stock On Track For Best Week On Record - StocktwitsStocktwits · Sat, 08 Aug 2026 06:03:50 GMTOTLK Stock Surges On FDA Lytenava Application Resubmission After Successful Appeal - StocktwitsStocktwits · Fri, 07 Aug 2026 22:28:56 GMTRetina specialists weigh in on FDA approval of bevacizumab-vikg (Lytenava) for wet AMD - Ophthalmology Times EuropeOphthalmology Times Europe · Sun, 02 Aug 2026 19:01:11 GMTOutlook: 'Hold' - Caution On LYTENAVA FDA Approval And Cash Needs (NASDAQ:OTLK) - Seeking AlphaSeeking Alpha · Tue, 28 Jul 2026 07:00:00 GMTOutlook Therapeutics wins FDA nod for Lytenava in neovascular AMD - Indian Pharma PostIndian Pharma Post · Tue, 28 Jul 2026 06:33:45 GMT